In vitro study of low-frequency ultrasound-enhanced transdermal transport of fentanyl and caffeine across human and hairless rat skin

被引:61
作者
Boucaud, A
Machet, L
Arbeille, B
Machet, MC
Sournac, M
Mavon, A
Patat, F
Vaillant, L
机构
[1] Univ Tours, Sch Med, Lab Ultrasons Signaux & Instrumentat, EA 2102, F-37032 Tours, France
[2] Univ Hosp, Dept Dermatol, F-37044 Tours, France
[3] Univ Tours, Sch Med, Dept Electron Microscopy, F-37032 Tours, France
[4] Univ Hosp, Dept Pathol Anat, F-37044 Tours, France
[5] Inst Rech Pierre Fabre, Dept Pharmaceut Technol & Formulat, F-31319 Labege, France
[6] Inst Rech Pierrre Fabre, Res Ctr, F-31322 Castanet Tolosan, France
关键词
sonophoresis; fentanyl; caffeine; transdermal delivery; human skin; hairless rat skin;
D O I
10.1016/S0378-5173(01)00820-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of low-frequency sonophoresis on fentanyl and caffeine permeation through human and hairless rat skin was studied in vitro. Experiments were performed using 20 kHz ultrasound applied at either continuous or discontinuous mode and with an average intensity of 2.5 W/cm(2). The results showed that low-frequency ultrasound enhanced the transdermal transport of both fentanyl and caffeine across human and hairless rat skin. This was explained by both increasing flux during sonication and shortening the lag time. Discontinuous mode was found to be more effective in increasing transdermal penetration of fentanyl while transdermal transport of caffeine was enhanced by both continuous and pulsed mode. Histological and electron microscopy studies showed that human and hairless rat skin was unaffected by ultrasound exposure. Further studies will be necessary to determine the relative contribution of ultrasound parameters in low-frequency ultrasound-induced percutaneous enhancement of drug transport. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:69 / 77
页数:9
相关论文
共 23 条
[1]  
BARRY B W, 1987, Journal of Controlled Release, V6, P85, DOI 10.1016/0168-3659(87)90066-6
[2]   SONOPHORESIS .1. THE USE OF HIGH-FREQUENCY ULTRASOUND TO ENHANCE TRANSDERMAL DRUG DELIVERY [J].
BOMMANNAN, D ;
OKUYAMA, H ;
STAUFFER, P ;
GUY, RH .
PHARMACEUTICAL RESEARCH, 1992, 9 (04) :559-564
[3]   Clinical, histologic, and electron microscopy study of skin exposed to low-frequency ultrasound [J].
Boucaud, A ;
Montharu, J ;
Machet, L ;
Arbeille, B ;
Machet, MC ;
Patat, F ;
Vaillant, L .
ANATOMICAL RECORD, 2001, 264 (01) :114-119
[4]  
CAPLAN RA, 1990, ADV PAIN RES THER, V14, P233
[5]  
ELIAS P, 1996, J DERMATOL, V23, P736
[6]   Effect of low frequency ultrasound on the in vitro percutaneous absorption of clobetasol 17-propionate [J].
Fang, JY ;
Fang, CL ;
Sung, KC ;
Chen, HY .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 191 (01) :33-42
[7]   ULTRASOUND AND MICROBUBBLES - THEIR GENERATION, DETECTION AND POTENTIAL UTILIZATION IN TISSUE AND ORGAN THERAPY - EXPERIMENTAL [J].
FRY, FJ ;
SANGHVI, NT ;
FOSTER, RS ;
BIHRLE, R ;
HENNIGE, C .
ULTRASOUND IN MEDICINE AND BIOLOGY, 1995, 21 (09) :1227-1237
[8]   Synergistic effects of chemical enhancers and therapeutic ultrasound on transdermal drug delivery [J].
Johnson, ME ;
Mitragotri, S ;
Patel, A ;
Blankschtein, D ;
Langer, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (07) :670-679
[9]   In vitro phonophoresis of mannitol, oestradiol and hydrocortisone across human and hairless mouse skin [J].
Machet, L ;
Cochelin, N ;
Patat, F ;
Arbeille, B ;
Machet, MC ;
Lorette, G ;
Vaillant, L .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 165 (02) :169-174
[10]   In vitro phonophoresis of digoxin across hairless mice and human skin: Thermal effect of ultrasound [J].
Machet, L ;
Pinton, J ;
Patat, F ;
Arbeille, B ;
Pourcelot, L ;
Vaillant, L .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 133 (1-2) :39-45